Libby Echo:Prio vs Zio ECG Utilization Software (ZEUS) System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Dyad Medical
VS
by iRhythm Technologies

AI Verdict

Libby Echo:Prio is designed for AI-powered analysis of echocardiogram images to provide decision support and automated cardiac measurements, focusing on structural and functional heart assessment. In contrast, the Zio ECG Utilization Software (ZEUS) System analyzes continuous ECG data from wearable monitors to aid in the diagnosis and management of cardiac arrhythmias. Therefore, clinicians would select Libby Echo:Prio for echocardiogram interpretation and ZEUS for long-term cardiac rhythm monitoring.

Choose Libby Echo:Prio if…

Choose Libby Echo:Prio if your primary need is rapid, AI-powered analysis of echocardiogram images to obtain automated cardiac measurements and receive immediate decision support. This tool is ideal for clinicians seeking consistent, data-driven quantification of cardiac function and a reliable second opinion during echocardiogram interpretation.

View Libby Echo:Prio →

Choose Zio ECG Utilization Software (ZEUS) System if…

Choose the Zio ECG Utilization Software (ZEUS) System if you require continuous, long-term ECG monitoring and AI-powered analysis for the detection and classification of cardiac arrhythmias. This platform is best suited for physicians managing patients where intermittent or elusive arrhythmias are suspected, providing comprehensive reports from wearable biosensors over an extended period.

View Zio ECG Utilization Software (ZEUS) System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Libby Echo:Prio Zio ECG Utilization Software (ZEUS) System
Pricing Custom Unknown
Deployment Cloud-based Cloud-based.
BAA Available No AI-estimated Unknown
FDA Status Yes AI-estimated Yes AI-estimated
HIPAA No AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio ECG Utilization Software (ZEUS) System

Tool B offers a ZioSuite web portal and a dedicated mobile application for healthcare professionals, enhancing accessibility and flexibility. It also explicitly supports HL7-based EHR integration, which streamlines clinical workflows more comprehensively than Tool A's general 'embedded in existing clinical workflows' claim.

Clinical Value

Zio ECG Utilization Software (ZEUS) System

Both tools are FDA-cleared and provide significant clinical value in cardiac diagnostics. However, Tool B's continuous ECG data analysis from wearable Zio monitors for up to 14 days offers a broader and more sustained diagnostic window for arrhythmias. This continuous monitoring, combined with proprietary deep-learned algorithms, provides a comprehensive end-of-wear report for physician review, potentially capturing intermittent events that a single echocardiogram analysis might miss.

Pricing & Value

Tie

Both Tool A and Tool B state that pricing is custom and requires contacting the vendor for details. Without publicly available pricing information for either product, it is impossible to conduct a head-to-head comparison of their cost-effectiveness or overall value.

Enterprise Readiness

Zio ECG Utilization Software (ZEUS) System

Tool B explicitly states it is HIPAA compliant and implies a Business Associate Agreement (BAA) is in place, which are critical for handling Protected Health Information (PHI) in enterprise healthcare settings. It also offers HL7-based EHR integration. In contrast, Tool A explicitly states 'no' for both HIPAA compliance and BAA, making it unsuitable for most healthcare enterprises in the US.

Innovation

Zio ECG Utilization Software (ZEUS) System

While both leverage AI and cloud technology, Tool B demonstrates greater innovation by integrating its AI-powered analysis with proprietary wearable Zio monitors for continuous ECG data collection. This combination of advanced biosensors with deep-learned algorithms for long-term, remote monitoring represents a more forward-thinking approach to cardiac diagnostics compared to Tool A's focus on automating echocardiogram analysis.

Support & Docs

Zio ECG Utilization Software (ZEUS) System

Tool B (Zio ECG Utilization Software) provides readily accessible 'Instructions for Use' documents and dedicated support channels, including phone and email for both providers and patients. Information regarding support and documentation for Tool A (Libby Echo:Prio) is not easily found through public web searches and appears to be conflated with a different consumer application.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Libby Echo:Prio Zio ECG Utilization Software (ZEUS) System
Name Libby Echo:Prio Zio ECG Utilization Software (ZEUS) System
Company Dyad Medical iRhythm Technologies
Primary Function FDA-cleared, cloud-based AI platform for fast, data-driven echocardiogram analysis, providing decision support and automated cardiac measurements for clinicians. AI-powered, cloud-based platform that analyzes continuous ECG data from wearable Zio monitors to aid physicians in the diagnosis and management of cardiac arrhythmias.
Key Focus Area AI-powered cardiac image analysis (echocardiograms) AI algorithm for arrhythmia detection and classification (continuous ECG data)
Input Data / Integration Echocardiogram images; Embedded in existing clinical workflows. Continuous ECG data from Zio wearable biosensors (Zio monitor, Zio Watch); HL7-based EHR integration.

Videos

Demos, reviews, and walkthroughs featuring Libby Echo:Prio and Zio ECG Utilization Software (ZEUS) System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Libby Echo:Prio by Dyad Medical analyzes echocardiogram images to provide data-driven cardiac measurements and decision support. In contrast, the Zio ECG Utilization Software (ZEUS) System by iRhythm Technologies analyzes continuous ECG data from wearable Zio monitors for arrhythmia detection and classification.
Libby Echo:Prio provides decision support and automated cardiac measurements for echocardiogram analysis, offering an immediately available second opinion for cardiac function quantification. The Zio ECG Utilization Software (ZEUS) System aids physicians in the diagnosis and management of cardiac arrhythmias through continuous ECG data analysis and comprehensive end-of-wear reports.
The Zio ECG Utilization Software (ZEUS) System integrates with proprietary Zio wearable biosensors (Zio monitor, Zio Watch) and offers HL7-based EHR integration. Libby Echo:Prio is designed to be embedded in existing clinical workflows and offers a cloud-based platform for remote access from any device.
Libby Echo:Prio is designed for Cardiology, Critical Care, and Radiology. The Zio ECG Utilization Software (ZEUS) System is intended for Cardiology, Family Medicine, and Internal Medicine.

Backers

Who funded each tool's parent company.

Zio ECG Utilization Software (ZEUS) System

AI Tool Finder
AI-powered search. Results may not be comprehensive.